Harvard Business Review

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. Laura Schneider for HBR. The failures continue.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

OCTOBER 20, 2016

In 2015, Global Trade Alert, an independent trade-monitoring group, cited at least 644 discriminatory trade measures imposed by the G20 economies with the U.S. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

MARCH 31, 2016

” In the article, a marketing expert explains why societal shifts would render the door-to-door salesman obsolete. Fast forward to 2015. In the late 20 th century, a proliferation of media options made buyers aware of products before talking to a salesperson, more so in B2C, but also in B2B markets.

B2B 8

B2B B2C Uncertainty Self-aware 8

Harvard Business Review

MAY 31, 2018

The pharmaceutical company Valeant raised the price of Cuprimine — invented in 1956 and used to treat Wilson’s disease, a rare condition in which the body cannot process copper — from about $500 to about $24,000 for a 30-day supply, causing outrage from consumers.

CEO 8

CEO Short-term Long-term McKinsey 8

Harvard Business Review

AUGUST 17, 2015

Cuba’s growth domestic product per capita in 2015 is approximately what it was in 1985. There was a spike in the 2000s when Venezuela began to provide petroleum at deeply discounted market prices, and that peaked just before the 2008-09 financial crisis. They don’t know how to market them effectively.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

DECEMBER 21, 2015

FactSet Research calculates that in the 12 months ending with September 2015, S&P 500 companies spent 64.6% At the end of fiscal 2015 (September 26), Apple had $187 billion in liquid assets abroad, up $50 billion from a year earlier. From 2005 to 2014, 458 S&P 500 companies expended $3.7 of net income, plus another 35.7%

Hedge 8

Hedge Proposal Pharmaceuticals Price 8

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

FEBRUARY 16, 2016

In response to our survey in late 2015, they told us that on economic matters, uncertainty abounds. If their projections turn out to be right, we should get ready for a bumpy road ahead, with market volatility and negative surprises. Results are based on all submissions as of December 1, 2015.

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JANUARY 5, 2018

The chief marketing officers at consumer products companies, the heads of design at luxury apparel companies, and the heads of logistics at large retailers are cases in point. They are not employees; they are contingent workers who are nonetheless vital to an organization’s R&D, marketing, and other key processes.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

DECEMBER 29, 2015

Today, the International Diabetes Federation (IDF) estimates that 415 million people, or about one in every 11, are living with the condition; in 2015, 28 million more adults have it than in 2014. With our knowledge and position in the market, how can we not do something to help? It has been for almost 100 years.

Health Care 8

Health Care NGO Pharmaceuticals Globalization 8

Harvard Business Review

APRIL 17, 2015

Both offer important lessons in social marketing — but mouthwash may still have one key advantage. Profits of Lambert Pharmaceutical went from $100,000 per year in 1920 to $4 million per year in 1927, a forty-fold increase impressive even by Silicon Valley standards. Let me explain.

Advertising 8

Advertising Information Technology Pharmaceuticals Audience 8

Harvard Business Review

JUNE 24, 2015

In this adaptation from the new book, Your Strategy Needs a Strategy (HBR Press, 2015), BCG strategy experts make sense of the all the different, and competing, approaches to strategy: Which strategy is right for your business? In a visionary setting, firms win by being the first to create a new market or to disrupt an existing one.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Strategy Driven

OCTOBER 10, 2016

As reaffirmed in Gartner’s 2015 report, How to Get Your Customer Service Employees to Care About the Customer , research shows “high levels of employee engagement contribute to higher levels of customer satisfaction.” CJ Stafford is president of Stafford Communications Group Inc.,

Strategy 50

Strategy Pharmaceuticals Learning-by-Doing Outsourcing 50

Harvard Business Review

MAY 25, 2017

From 2015 to 2016, investors poured more than $8 billion into funding these tools. The pipeline for new drugs is bursting, and new devices and tools in the rapidly emerging digital health space will come to market more quickly. Investors are already keenly focused on this area, with many startups competing for a slice of the market.

Health Care 9

Health Care Trends Venture Funding Technology 9

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 15

Price Pharmaceuticals Company Health Care 15

Harvard Business Review

APRIL 6, 2017

I help the University of Utah hospital system manage its drug budgets and medication use policies, and in 2015 I got sticker shock. The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. Problems with generic drug makers. Ways to Fix the System.

System 13

System Pharmaceuticals Company Sample 13

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. We analyzed every conflict minerals report submitted to the SEC in 2014, 2015, and 2016 (though our paper only includes results for the first two years). stock markets. Filing companies were primarily based in the U.S.

Supply Chain 9

Supply Chain Productivity Products Company 9